Literature DB >> 1650841

Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.

L M Ryan1, J W Rachow, D J McCarty.   

Abstract

The enzyme nucleoside triphosphate pyrophosphohydrolase (NTPPPH) is present in all joint fluids and on intraarticular cells. It generates inorganic pyrophosphate (PPi) from nucleoside triphosphate substrate, thus serving as a potential source of the PPi which forms in the cartilages of patients with calcium pyrophosphate dihydrate (CPPD) crystal deposition. NTPPPH is also important in matrix vesicle induced calcification with basic calcium phosphate (BCP) crystals. An articular substrate for this enzyme was sought. ATP was measured in the joint fluids from 107 patients with various forms of arthritis. Synovial fluid ATP levels were higher in patients with CPPD deposits than in osteoarthritis (p less than 0.02) or rheumatoid arthritis (p less than 0.002). ATP also correlated with PPi concentration (p less than 0.05) and with the presence of BCP crystals (p less than 0.05), but not with cellularity of the fluid, NTPPPH activity, or age of the donor. This substrate for NTPPPH may contribute to CPPD crystal deposition by generating PPi and may stimulate matrix vesicle induced formation of BCP crystals in several forms of arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650841

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

Review 1.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

Review 2.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

Review 3.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

4.  P2X7 ionotropic receptor is functionally expressed in rabbit articular chondrocytes and mediates extracellular ATP cytotoxicity.

Authors:  Hitoshi Tanigawa; Futoshi Toyoda; Kosuke Kumagai; Noriaki Okumura; Tsutomu Maeda; Hiroshi Matsuura; Shinji Imai
Journal:  Purinergic Signal       Date:  2018-05-29       Impact factor: 3.765

5.  Rapid estrogenic effects on TMJ-responsive brainstem neurons.

Authors:  A Tashiro; K Okamoto; D A Bereiter
Journal:  J Dent Res       Date:  2011-11-04       Impact factor: 6.116

6.  P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.

Authors:  Juliana Maia Teixeira; Franciane Bobinski; Carlos Amílcar Parada; Kathleen A Sluka; Cláudia Herrera Tambeli
Journal:  Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.590

7.  Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.

Authors:  L M Ryan; D J McCarty
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

8.  Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

Review 9.  P2X3 receptors and peripheral pain mechanisms.

Authors:  R Alan North
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

10.  Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.

Authors:  R Huang; M Rosenbach; R Vaughn; D Provvedini; N Rebbe; S Hickman; J Goding; R Terkeltaub
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.